tiprankstipranks
Trending News
More News >
Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
US Market
Advertisement

Fortrea Holdings Inc. (FTRE) Earnings Dates, Call Summary & Reports

Compare
100 Followers

Earnings Data

Report Date
Mar 16, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.17
Last Year’s EPS
0.18
Same Quarter Last Year
Based on 10 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a mix of positive developments such as revenue growth, improved book-to-bill ratio, and strong cash position, alongside challenges like decreased adjusted EBITDA and a competitive FSP pricing environment. The positive aspects, including strategic innovations and high client satisfaction, generally outweighed the negatives.
Company Guidance
During the Fortrea Q3 2025 earnings call, CEO Anshul Thakral reported solid financial performance, with revenue reaching $701.3 million and adjusted EBITDA at $50.7 million. The company showcased a robust backlog exceeding $7.6 billion, with an improved book-to-bill ratio of 1.13x, a noteworthy increase from the previous quarter, and a trailing 12-month ratio of 1.07x. Fortrea's operational metrics highlighted significant improvements, including a 33% reduction in time to site selection and a 5-month early completion of enrollment in a Phase II Alzheimer's study. The Net Promoter Score also showed a sequential increase, reflecting enhanced client satisfaction. Additionally, the company reported a successful cash position, with an operating cash flow of $87 million in Q3, and a 13-day improvement in days sales outstanding (DSO) from the previous quarter. As part of their strategic focus, Fortrea emphasized commercial, operational, and financial excellence, targeting further margin improvements and a stronger competitive positioning in the clinical research market.
Solid Third Quarter Revenue
Revenue for Q3 was $701.3 million, representing a 3.9% increase year-over-year, driven by increases in both clinical pharmacology and clinical development businesses.
Improved Book-to-Bill Ratio
The book-to-bill ratio improved to 1.13x, significantly better than the second quarter, with a trailing 12-month ratio of 1.07x.
Strong Cash Position
Fortrea's cash position is robust with over $0.5 billion in available liquidity, aided by strategic actions like the tender offer to repurchase outstanding senior secured notes.
Operational and Strategic Innovations
Introduction of AI-powered tools like Accelerate Risk Radar and Start My Day to improve efficiency and risk management in clinical trials.
Improved Client Satisfaction
Sequential improvement in Net Promoter Scores, reflecting operational excellence and client satisfaction.
Employee Engagement and Client Relations
High employee morale and strong client relationships were emphasized, with strategic travel and engagement from the CEO.

Fortrea Holdings Inc. (FTRE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FTRE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 16, 2026
2025 (Q4)
0.17 / -
0.18
Nov 05, 2025
2025 (Q3)
0.16 / 0.12
0.23-47.83% (-0.11)
Aug 06, 2025
2025 (Q2)
0.08 / 0.19
-0.03733.33% (+0.22)
May 12, 2025
2025 (Q1)
-0.05 / 0.02
-0.04150.00% (+0.06)
Mar 03, 2025
2024 (Q4)
0.36 / 0.18
0.19-5.26% (-0.01)
Nov 08, 2024
2024 (Q3)
0.25 / 0.23
0.24-4.17% (>-0.01)
Aug 12, 2024
2024 (Q2)
0.07 / -0.03
0.52-105.77% (-0.55)
May 13, 2024
2024 (Q1)
<0.01 / -0.04
0.454-108.81% (-0.49)
Mar 11, 2024
2023 (Q4)
0.23 / 0.19
Nov 13, 2023
2023 (Q3)
0.16 / 0.24
0.682-64.81% (-0.44)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FTRE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$9.70$11.95+23.20%
Aug 06, 2025
$6.56$6.58+0.30%
May 12, 2025
$6.15$5.19-15.61%
Mar 03, 2025
$13.85$10.38-25.05%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Fortrea Holdings Inc. (FTRE) report earnings?
Fortrea Holdings Inc. (FTRE) is schdueled to report earning on Mar 16, 2026, Before Open (Confirmed).
    What is Fortrea Holdings Inc. (FTRE) earnings time?
    Fortrea Holdings Inc. (FTRE) earnings time is at Mar 16, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is FTRE EPS forecast?
          FTRE EPS forecast for the fiscal quarter 2025 (Q4) is 0.17.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis